Fathom vs Carevoyance: Live Census vs Claims Tool
Carevoyance was a med device targeting and claims analysis tool, acquired by Definitive Healthcare and now sold inside Definitive's broader platform.
Where Carevoyance Is the Right Call
- Teams already inside the Definitive ecosystem who get Carevoyance bundled in
- Med device targeting workflows built around claims analysis
- Organizations comfortable with enterprise contracts and enterprise timelines
Where It Breaks for Field Teams
- Post-acquisition roadmap uncertainty. The standalone product's future now sits inside Definitive's priorities.
- Pricing is bundled into enterprise contracts, publicly reported around $20,000 or more per year and climbing.
- Claims-based core, so cash-pay markets and real-time signals stay out of view.
- Users report stagnation since the acquisition, with pressure to upgrade into Definitive's wider, pricier platform.
Fathom vs Carevoyance, Side by Side
An honest look at where each approach excels, including where Carevoyance has the advantage.
| Criteria | Fathom | Carevoyance |
|---|---|---|
| Data source | Real-time web intelligence plus publicly available federal sources | Claims analysis, now inside Definitive's platform |
| Coverage | Full private practice and SMB coverage, 48,198 verified US aesthetic practices | Med device targeting, claims-visible providers |
| Update cadence | Real-time, accounts rescore as the market moves | Claims cycles, roadmap uncertain post-acquisition |
| Rep workflow | Built for reps: scored map, call briefs, next-best-account routing | Claims reports, increasingly bundled into enterprise UI |
| Account scoring | Dual Readiness and Opportunity scores from 200+ data points | Claims-derived targeting lists |
| Pricing model | Engagement-based, built for mid-market budgets | Bundled into Definitive contracts, publicly reported $20,000+ |
How Fathom Is Different
Independent and shipping fast
Fathom is bootstrapped, profitable, and answers to customers, not an acquirer's product committee. Fortune reviewed the company's financial records in April 2026 and reported $300,000 estimated ARR within 12 weeks of launch. The roadmap moves at customer speed.
Beyond claims
Fathom combines real-time web intelligence with publicly available federal sources and proprietary compiled datasets. Carevoyance's claims core shares the same structural blind spot as every claims tool: cash-pay private practices barely exist in the data.
Practice-level truth
Fathom's census of 48,198 verified US aesthetic practices includes verified install base, provider rosters, and live service menus. Reps see what a practice owns and offers today, not what it billed quarters ago.
Results you can point to
Tiger Aesthetics opened 225 net new accounts in Q1 2026 on Fathom, after zero net new the prior year. Stanford's Digital Economy Lab profiled Fathom in its Enterprise AI Playbook as AI performing work it classifies as previously impossible.
Switching from Carevoyance
Carevoyance users switching to Fathom keep their territories and their claims-era target lists, which can be loaded as reference data. What changes: static claims reports become live scored accounts with generated briefs, and pricing shifts from bundled enterprise contracts to engagement-based scoping. Because Fathom ships configured for your vertical, migration is measured in weeks, not quarters, and reps do not need to relearn how they work a territory.
Frequently Asked Questions
What happened to Carevoyance?
Carevoyance was acquired by Definitive Healthcare. The product now lives inside Definitive's platform, and users report the standalone roadmap has slowed while pricing folds into broader enterprise contracts. That is the public record, not our spin.
Is Fathom a direct Carevoyance replacement?
For med device field targeting, yes, with more current data. Fathom adds real-time web intelligence, verified install base, and dual account scores on top of the claims signals Carevoyance was built on, in a rep-facing product.
How does pricing compare?
Carevoyance pricing is now bundled inside Definitive contracts, publicly reported around $20,000 or more per year. Fathom uses engagement-based pricing scoped per customer, built for mid-market manufacturers. Contact dan@fathom-ai.net for specifics.
Does Fathom cover the same claims data?
Fathom includes publicly available federal sources, CMS data among them, as one layer of its 200+ data points per practice. It then adds what claims cannot show: live services, providers, devices, and digital presence.
Why switch now instead of waiting?
Acquisition integrations historically freeze products for quarters while roadmaps merge. Meanwhile every week on stale claims data is a week your competitor's reps work accounts yours cannot see. Migration takes weeks, so the cost of waiting compounds.
See What Carevoyance Cannot Show You
Get a live scoring of your territory with real-time install base data, practice-level intelligence, and generated sales briefs.